After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ENTO belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Entero Therapeutics Inc is $2.07M. A total of 5.03 million shares were traded on the day, compared to an average of 1.55M shares.
In the most recent transaction, Romano Sarah sold 727 shares of ENTO for 0.64 per share on Jan 06 ’25. After the transaction, the Chief Financial Officer now owns 17,287 company shares. In a previous transaction on Oct 09 ’24, Romano Sarah sold 476 shares at 0.45 per share. ENTO shares that Chief Financial Officer owns now total 18,014.
Among the insiders who sold shares, Romano Sarah disposed of 621 shares on Jul 02 ’24 at a per-share price of $1.07. This resulted in the Chief Financial Officer holding 18,490 shares of ENTO after the transaction. In another insider transaction, SAPIRSTEIN JAMES sold 1,289 shares at $1.07 per share on Jul 02 ’24. Company shares held by the Chairman and CEO now total 35,816.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ENTO has a high of $2.86 and a low of $0.19.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ENTO’s latest balance sheet shows that the firm has $8.25M in Cash & Short Term Investments as of fiscal 2021. There were $1.03M in debt and $12.30M in liabilities at the time. Its Book Value Per Share was -$1.09, while its Total Shareholder’s Equity was -$7.82M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ENTO is Buy with a score of 0.00.
